Exosomal miR-145-5p inhibits papillary thyroid cancer by targeting TPM3 and inactivating the PI3K-Akt pathway
Yunfeng Weng, Xianjiao Cao, Wenyan Song, Qingqing He · 2026
Read Exosomal miR-145-5p inhibits papillary thyroid cancer by targeting TPM3 and inactivating the PI3K-Akt pathway by Yunfeng Weng, Xianjiao Cao, Wenyan Song, Qingqing He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13631643.txt.
Description
Yunfeng Weng, Xianjiao Cao, Wenyan Song, and Qingqing He study a tiny RNA molecule that slows thyroid cancer, in a research paper from 2026. The cancer is the papillary type, the most common form. The molecule travels in small packets called exosomes, which cells use to send messages.
Data analysis showed a gene called TPM3 is switched up in this cancer and linked to spread and stem-like traits. Loading exosomes with the RNA and feeding them to cancer cells cut their growth, movement, and invasion. Blocking the RNA reversed the effect. The authors say this RNA-and-gene pair could be a target for new therapy.
Catalog record
| CREATOR | Yunfeng Weng, Xianjiao Cao, Wenyan Song, Qingqing He |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |